(Q42595010)

3 November 2017

Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study (English)

1 reference

3 November 2017

1 reference

Anna Campanati

1

1 reference

3 November 2017

Luca Penna

2

1 reference

3 November 2017

Teresa Guzzo

3

1 reference

3 November 2017

Lucia Menotta

4

1 reference

3 November 2017

Barbara Silvestri

5

1 reference

3 November 2017

Giovanni Lagalla

6

1 reference

3 November 2017

Rosaria Gesuita

7

1 reference

3 November 2017

Annamaria Offidani

8

1 reference

3 November 2017

1 January 2003

1 reference

3 November 2017

Clinical Therapeutics

1 reference

3 November 2017

25

1 reference

3 November 2017

1

1 reference

3 November 2017

298-308

1 reference

Ultrastructure of the hyperhidrotic eccrine sweat gland

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Pharmacologic characterization of botulinum toxin for basic science and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Evidence-based medicine: botulinum toxin in focal hyperhidrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Botulinum toxin therapy for palmar hyperhidrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Botulinum toxin A for axillary hyperhidrosis (excessive sweating).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in application

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Axillary hyperhidrosis: treatment with botulinum toxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Treatment of plantar hyperhidrosis with dermojet injections of botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Botulinum A toxin improves life quality in severe primary focal hyperhidrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

The quality of life in acne: a comparison with general medical conditions using generic questionnaires.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990041-5

7 January 2021

10.1016/S0149-2918(03)90041-5

Identifiers

DOI

1 reference

3 November 2017

1 reference